Evidence map›Paper›PMID 38543527›Full record

ArticleMicroorganisms2024

An Evaluation of the Antibacterial, Antileishmanial, and Cytotoxic Potential of the Secondary Metabolites of

Virlanna Larissa Santos de Azevedo, Fernanda Costa Rosa, Leo Ruben Lopes Dias, Lucas Abrantes Batista, Mariana Costa Melo, Luis Alfredo Torres Sales, Abia de Jesus Martins Branco, Thalison Rômulo Rocha Araújo, Rita de Cássia Mendonça de Miranda, Amanda Silva Dos Santos Aliança

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Virlanna Larissa Santos de AzevedoPostgraduate Department, Postgraduate Program in Bioscience Applied to Health, Ceuma University, São Luis 65075-120, MA, Brazil.
Fernanda Costa RosaPostgraduate Department Postgraduate Program in Bionorte, Ceuma University, São Luís 65075-120, MA, Brazil.ORCID 0000-0003-2138-0869
Leo Ruben Lopes DiasPostgraduate Department, Postgraduate Program in Bioscience Applied to Health, Ceuma University, São Luis 65075-120, MA, Brazil.ORCID 0000-0001-6303-4927
Lucas Abrantes BatistaPostgraduate Program in Parasitic Biology, Universidade Federal do Rio Grande do Norte, Natal 59078-900, RN, Brazil.
Mariana Costa MeloGraduate Department, Ceuma University, São Luis 65075-120, MA, Brazil.
Luis Alfredo Torres SalesDepartment of Microbiology, PhD in Biological Sciences, University of São Paulo, São Paulo 05508-900, SP, Brazil.
Abia de Jesus Martins BrancoGraduate Department, Ceuma University, São Luis 65075-120, MA, Brazil.
Thalison Rômulo Rocha AraújoGraduate Department, Ceuma University, São Luis 65075-120, MA, Brazil.
Rita de Cássia Mendonça de MirandaPostgraduate Department, Postgraduate Program in Bioscience Applied to Health, Ceuma University, São Luis 65075-120, MA, Brazil.ORCID 0000-0003-2116-1797
Amanda Silva Dos Santos AliançaPostgraduate Department, Postgraduate Program in Bioscience Applied to Health, Ceuma University, São Luis 65075-120, MA, Brazil.
Universidade Ceuma · BRUniversidade de São Paulo · BRUniversidade Federal do Rio Grande do Norte · BR

Funding

Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão FAPEMA ACT-01787/21
6 · The paper itself

Abstract

This study aimed to evaluate the antibacterial, leishmanicidal, and cytotoxic potential of metabolites produced by bacteria isolated from rhizosphere soil samples. The bacterium was identified by genome sequencing as

Indexed as

actinomycetesantimicrobialsbiotechnologycytotoxicityleishmanicidal

Identifiers

PMID38543527
PMCPMC10972310
OpenAlexW4392193434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.